TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Opthea Ltd (OPT)

Healthcare Biotechnology
3.40 $
+7.2% vs. previous close
Closing price · As of: 2. Jul 2026

Opthea Ltd (OPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2024), "Revenue" came in at 0.1 million AUD. Tick rows to compare them in a chart.

All figures in millions of AUD.

Income Statement OPT
Tick rows to compare them in a chart (up to 4) 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
0.0 0.1 0.1 0.1 0.1 0.2 0.1
0.0 0.0 0.0 0.3 0.5 0.6 0.2 0.3 0.1
0.0 0.0 0.0 -0.2 -0.4 -0.5 -0.1 -0.1 0.0
3.1 3.4 4.3 3.6 4.8 25 31 17 35 108 182 176
3.1 2.7 2.4 2.9 3.3 2.7 5.1 6.6 12 16 19 15
6.9 6.6 6.8 8.1 9.9 30 36 25 53 133 223 192
-7.2 -6.3 -7.0 -8.1 -9.9 -30 -37 -25 -53 -133 -223 -192
0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 22 0.2 13 30
-6.0 -6.4 -6.2 -8.1 -9.4 -29 -36 -24 -67 -137 -221 -230
-1.4 -2.7 -2.1 -1.6 -3.2 -12 15 8.3 -6.6 -8.7 -8.8 -9.4
-4.3 -3.8 -4.1 -6.5 -6.2 -17 -21 -16 -61 -128 -212 -220
-6.5 -6.8 -8.1 -7.7 -9.8 -30 -37 -25 -53 -133 -223 -200

Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?